145 related articles for article (PubMed ID: 2112757)
1. An extensive study of donor plasmapheresis using a membrane method by the special study group of the Japanese Red Cross Society.
Ikeda H; Tomono T; Sakai E; Endo N; Yokoyama S; Ogawa M; Shiraki H; Kameko S; Sekiguchi S
Prog Clin Biol Res; 1990; 337():503-6. PubMed ID: 2112757
[No Abstract] [Full Text] [Related]
2. [Donor selection for the production of factor XIII preparations].
Uteg KH; Tausendfreund K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):447-55. PubMed ID: 2414175
[TBL] [Abstract][Full Text] [Related]
3. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
4. Whole blood collection using metered anticoagulation for production of Factor VIII and Factor IX.
Penny A; Pinner M; Townley A; Mosley P; Smith J; Lane R; Munford C; Robinson A
Prog Clin Biol Res; 1990; 337():487-9. PubMed ID: 2112756
[No Abstract] [Full Text] [Related]
5. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
[TBL] [Abstract][Full Text] [Related]
6. Plasma fractionation in blood transfusion service.
Haskó F; Salamon M; Bartha K; Dobó P
Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
[TBL] [Abstract][Full Text] [Related]
7. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
[TBL] [Abstract][Full Text] [Related]
8. Pilot study for large-scale plasma procurement using automated plasmapheresis.
Robinson AE; Penny AF; Smith J; Tovey DL
Vox Sang; 1983 Mar; 44(3):143-50. PubMed ID: 6220520
[TBL] [Abstract][Full Text] [Related]
9. A prospective trial assessing the safety and efficacy of collecting up to 840 mL of plasma in conjunction with saline infusion during plasmapheresis.
Buzza M; Marks DC; Capper H; Cassin E; Badcock CA; Reid S; Kwok M; Yang H; Lee J; Corrigan C; Hartkopf-Theis T; Keller A
Transfusion; 2012 Aug; 52(8):1806-13. PubMed ID: 22348664
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of different methods of blood separation in performing plasma- and cytapheresis].
Ryzhko VV; Gorodetskiĭ VM; Rogova EM
Ter Arkh; 1988; 60(5):85-8. PubMed ID: 3175936
[TBL] [Abstract][Full Text] [Related]
11. [Principles and methods of using apparatus for plasmocytapheresis with donors and patients].
Kalinin NN
Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):11-6. PubMed ID: 7279882
[No Abstract] [Full Text] [Related]
12. Adverse reactions in healthy blood donors undergoing plasmapheresis.
Schroeder ML; Buskard N; Herbert M; Kelton J; Rock G; Sternbach M
Prog Clin Biol Res; 1990; 337():485-6. PubMed ID: 2353009
[No Abstract] [Full Text] [Related]
13. Factor VIII collection by pheresis.
McLeod BC; Sassetti RJ; Cole ER; Pierce MI
Lancet; 1980 Sep; 2(8196):671-3. PubMed ID: 6106786
[TBL] [Abstract][Full Text] [Related]
14. Observation of the changes of plasma proteins after long term plasmapheresis.
Grgicević D; Pistotnik M; Pende B
Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
[TBL] [Abstract][Full Text] [Related]
15. Selective plasmapheresis using special secondary on line filters in therapy of immune disorders.
Siami G; Stone WJ
Prog Clin Biol Res; 1990; 337():355-7. PubMed ID: 2352994
[No Abstract] [Full Text] [Related]
16. Donor plasmapheresis and regional self sufficiency.
Urbaniak SJ
Int J Artif Organs; 1984 Jan; 7(1):43-6. PubMed ID: 6421755
[No Abstract] [Full Text] [Related]
17. Starting a plasmapheresis program with hollow-fiber filtration.
van der Does JA; van Antwerpen CE
Vox Sang; 1986; 51 Suppl 1():45-8. PubMed ID: 3090785
[TBL] [Abstract][Full Text] [Related]
18. [Intensive plasmapheresis (programs, laboratory monitoring, complications)].
Malakhovskiĭ IuE; Manerov FK; Makarets BG; Pedanov EA; Romanov MG
Ter Arkh; 1989; 61(7):55-60. PubMed ID: 2588144
[TBL] [Abstract][Full Text] [Related]
19. Successful procedure for plasmapheresis and immuno adsorption treatment.
Hosokawa S; Oyamaguchi A; Yoshida O
Prog Clin Biol Res; 1990; 337():371-3. PubMed ID: 2191328
[No Abstract] [Full Text] [Related]
20. Plasmapheresis in healthy donors in the Netherlands: cohort study of risk factors for donor complications.
Wiersum-Osselton JC; Marijt-van der Kreek T; van Dongen R
Transfus Apher Sci; 2013 Apr; 48(2):163. PubMed ID: 23809816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
